ICD-10-CM Billable Code

T42.0

Poisoning by, adverse effect of and underdosing of hydantoin derivatives

Clinical Classification Guidelines

Medical Intelligence & Overview

Hydantoin derivatives are a class of medications often used to treat seizures and epilepsy. While these drugs can be highly effective in managing neurological conditions, overdose or adverse reactions can lead to poisoning. ICD-10 code T42.0 covers cases involving poisoning, adverse effects, or underdosing of hydantoin derivatives. Recognizing the causes, symptoms, and management strategies associated with this condition is essential for health professionals and patients alike.

Causes & Symptoms

Clinical Causes: Accidental overdose due to miscalculation or misunderstanding of dosage instructions Intentional overdose in suicide attempts or self-harm behaviors Chemical interactions with other medications that increase toxicity Use of expired or improperly stored medication leading to increased potency Underdosing, which may result in subtherapeutic effects but can sometimes cause adverse reactions if the medication levels fluctuate unexpectedly Allergic hypersensitivity to hydantoin derivatives Metabolic or genetic factors impairing drug processing

Key Symptoms: Nausea and vomiting Dizziness or lightheadedness Ataxia (loss of coordination) Drowsiness or fatigue Confusion or agitation Respiratory depression in severe cases Gastrointestinal disturbances Tremors or involuntary movements Skin rash or hypersensitivity reactions Seizure activity may worsen or fluctuate

Diagnostic & Treatment

Diagnosis Path: Diagnosis primarily involves reviewing patient history, medication usage, and exposure details. Blood tests measuring hydantoin derivative levels can help confirm poisoning or toxicity. Additional assessments such as neurologic examinations, liver function tests, and imaging studies may be performed to evaluate complication extent and rule out other causes. Gathering information about timing, dosage, and symptoms is vital for accurate diagnosis.

Treatment Protocols: Management of hydantoin derivative poisoning focuses on supportive care and preventing further absorption of the drug. Key steps include: - Immediate stabilization of vital signs and airway management - Activated charcoal administration if ingestion was recent to limit absorption - Intravenous fluids to maintain hydration and support renal clearance - Monitoring and managing neurological symptoms, including seizure activity - Use of specific antidotes is not typically available; treatment is mainly supportive - Hemodialysis in severe cases to remove the drug from circulation - Adjusting or discontinuing medication under medical supervision to prevent recurrence Close observation in a healthcare setting is often necessary to ensure recovery and manage any complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T42.0 a billable ICD-10 code?
Yes, T42.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T42.0?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of hydantoin derivatives and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

derivatives adverse underdosing effect hydantoin poisoning